Explore
Trendline
Expion360 Reports Q1 2026 Financial Results with Revenue Decline and Increased Net Loss
Expion360 Reports Q1 2026 Financial Results with Revenue Decline and Increased Net Loss
Read More
Trendline
Expion360 Reports Revenue Decline and Increased Net Loss in Q1 2026
Expion360 Reports Revenue Decline and Increased Net Loss in Q1 2026
Read More
Trendline
Syntec Optics Reports Q1 2026 Financial Results Amid Shipment Delays and Strategic Growth Initiatives
Syntec Optics Reports Q1 2026 Financial Results Amid Shipment Delays and Strategic Growth Initiatives
Read More
Trendline
Vuzix Reports Q1 2026 Financial Results with Continued Investment in Development
Vuzix Reports Q1 2026 Financial Results with Continued Investment in Development
Read More
Trendline
Latch, Inc. Reports Improved Financial Performance in Q1 2026 with Reduced Losses
Latch, Inc. Reports Improved Financial Performance in Q1 2026 with Reduced Losses
Read More
Trendline
Suncrete Reports 64% Revenue Increase in Q1 2026, Expands Operations
Suncrete Reports 64% Revenue Increase in Q1 2026, Expands Operations
Read More
Trendline
Syntec Optics Reports Q1 2026 Financial Results Amid Shipment Delays
Syntec Optics Reports Q1 2026 Financial Results Amid Shipment Delays
Read More
Trendline
DynaResource Reports Improved Q1 2026 Financial Results Amid Operational Challenges
DynaResource Reports Improved Q1 2026 Financial Results Amid Operational Challenges
Read More
Trendline
LM Funding America Reports Decline in Q1 2026 Financial Results Amid Bitcoin Price Drop
LM Funding America Reports Decline in Q1 2026 Financial Results Amid Bitcoin Price Drop
Read More
Trendline
Guided Therapeutics Inc Reports No Revenue and Increased Net Loss in Q1 2026
Guided Therapeutics Inc Reports No Revenue and Increased Net Loss in Q1 2026
Read More
Trendline
Hydrofarm Holdings Group Reports Significant Decline in First Quarter 2026 Financial Results
Hydrofarm Holdings Group Reports Significant Decline in First Quarter 2026 Financial Results
Read More
Trendline
Inhibrx Reports Financial Results and Clinical Trial Updates for Q1 2026
Inhibrx Reports Financial Results and Clinical Trial Updates for Q1 2026
Read More